FBRX – Forte Biosciences Inc
Forte Biosciences, Inc.FBRX
$17.00Name : Forte Biosciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $348,139,872.00
EPSttm : -4.58
Forte Biosciences, Inc.
$17.00
8.49%$1.33
FBRX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
6.8
Margin Of Safety %
Put/Call OI Ratio
0.86
EPS Next Q Diff
0.45
EPS Last/This Y
0.7
EPS This/Next Y
-0.13
Price
17.03
Target Price
63.75
Analyst Recom
1
Performance Q
-39.87
Upside
-490.8%
Beta
2.9
Ticker: FBRX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | FBRX | 25.93 | 0.18 | 0.71 | 1644 |
| 2026-05-12 | FBRX | 24.15 | 0.18 | 26.00 | 1656 |
| 2026-05-13 | FBRX | 24.53 | 0.18 | 999.99 | 1666 |
| 2026-05-14 | FBRX | 23.8 | 0.20 | 1.20 | 1690 |
| 2026-05-15 | FBRX | 23.1 | 0.20 | 19.75 | 1698 |
| 2026-05-18 | FBRX | 21.02 | 1.23 | 1.54 | 272 |
| 2026-05-19 | FBRX | 19.97 | 1.28 | 1.10 | 338 |
| 2026-05-20 | FBRX | 20.25 | 1.26 | 1.33 | 402 |
| 2026-05-21 | FBRX | 22.08 | 1.26 | 0.75 | 415 |
| 2026-05-22 | FBRX | 21.7 | 1.26 | 0.50 | 424 |
| 2026-05-26 | FBRX | 21.87 | 1.25 | 2.00 | 426 |
| 2026-05-27 | FBRX | 21.4 | 1.15 | 0.76 | 446 |
| 2026-05-28 | FBRX | 20.84 | 1.09 | 2.75 | 511 |
| 2026-05-29 | FBRX | 19 | 1.14 | 1.00 | 519 |
| 2026-06-02 | FBRX | 18.21 | 1.01 | 1.00 | 544 |
| 2026-06-03 | FBRX | 16.93 | 1.01 | 0.88 | 547 |
| 2026-06-04 | FBRX | 16.59 | 0.99 | 0.28 | 556 |
| 2026-06-05 | FBRX | 16.56 | 0.88 | 0.13 | 580 |
| 2026-06-08 | FBRX | 15.78 | 0.88 | 1.38 | 585 |
| 2026-06-09 | FBRX | 17.07 | 0.86 | 2.00 | 606 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | FBRX | 25.94 | 15.3 | - | -4.26 |
| 2026-05-12 | FBRX | 24.22 | 15.3 | - | -4.26 |
| 2026-05-13 | FBRX | 24.60 | 15.3 | - | -4.26 |
| 2026-05-14 | FBRX | 24.02 | 15.3 | - | -4.26 |
| 2026-05-15 | FBRX | 23.06 | 15.3 | - | -4.26 |
| 2026-05-18 | FBRX | 20.95 | -9.4 | - | -4.17 |
| 2026-05-19 | FBRX | 20.01 | -9.4 | - | -4.17 |
| 2026-05-20 | FBRX | 20.30 | -4.9 | - | -4.17 |
| 2026-05-21 | FBRX | 22.07 | -4.9 | - | -4.01 |
| 2026-05-22 | FBRX | 21.62 | -4.9 | - | -4.01 |
| 2026-05-26 | FBRX | 21.87 | -4.9 | - | -4.01 |
| 2026-05-27 | FBRX | 21.43 | -4.9 | - | -4.01 |
| 2026-05-28 | FBRX | 20.82 | -4.9 | - | -4.01 |
| 2026-05-29 | FBRX | 19.05 | -4.9 | - | -4.01 |
| 2026-06-01 | FBRX | 19.02 | -4.9 | - | -4.01 |
| 2026-06-02 | FBRX | 18.20 | -4.9 | - | -4.01 |
| 2026-06-03 | FBRX | 16.98 | -4.9 | - | -4.01 |
| 2026-06-04 | FBRX | 16.69 | -4.9 | - | -4.01 |
| 2026-06-05 | FBRX | 16.56 | -4.9 | - | -4.01 |
| 2026-06-08 | FBRX | 15.78 | -4.9 | - | -4.01 |
| 2026-06-09 | FBRX | 17.03 | -4.9 | - | -4.01 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | FBRX | 0.38 | 3.55 | 4.95 |
| 2026-05-12 | FBRX | 0.38 | 3.55 | 6.09 |
| 2026-05-13 | FBRX | 0.38 | 3.55 | 6.09 |
| 2026-05-14 | FBRX | 0.38 | 3.55 | 6.09 |
| 2026-05-15 | FBRX | 0.38 | 3.55 | 6.09 |
| 2026-05-18 | FBRX | 0.38 | 2.53 | 5.77 |
| 2026-05-19 | FBRX | 0.60 | 2.53 | 5.77 |
| 2026-05-20 | FBRX | 0.60 | 2.53 | 5.77 |
| 2026-05-21 | FBRX | 0.60 | 2.53 | 6.00 |
| 2026-05-22 | FBRX | 0.42 | 2.53 | 6.00 |
| 2026-05-26 | FBRX | 0.42 | 11.23 | 6.11 |
| 2026-05-27 | FBRX | 0.35 | 11.23 | 6.11 |
| 2026-05-28 | FBRX | 0.35 | 11.23 | 6.80 |
| 2026-05-29 | FBRX | 0.35 | 11.23 | 6.80 |
| 2026-06-02 | FBRX | 0.35 | 10.78 | 6.80 |
| 2026-06-03 | FBRX | 0.35 | 10.78 | 6.80 |
| 2026-06-04 | FBRX | 0.35 | 10.78 | 6.80 |
| 2026-06-05 | FBRX | 0.35 | 10.78 | 6.80 |
| 2026-06-08 | FBRX | 0.35 | 10.78 | 6.80 |
| 2026-06-09 | FBRX | 0.35 | 10.78 | 6.80 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.45
Avg. EPS Est. Current Quarter
-1.01
Avg. EPS Est. Next Quarter
-1
Insider Transactions
0.35
Institutional Transactions
10.78
Beta
2.9
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
5
Growth Score
18
Sentiment Score
43
Actual DrawDown %
98.4
Max Drawdown 5-Year %
-99.6
Target Price
63.75
P/E
Forward P/E
PEG
P/S
P/B
5.62
P/Free Cash Flow
EPS
-5.11
Average EPS Est. Cur. Y
-4.01
EPS Next Y. (Est.)
-4.14
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.42
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
-4
EPS 1 30Days Diff
-4.01
EBIT Estimation
◆
FBRX
Healthcare
$17.00
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
33
Range 1M
12.7%
Sup Dist
10.5%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
12.8%
EPS NY
-3.6%
52W%
29.5%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+275% upside
Upside
+275%
Quality
5
Forte Biosciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 22
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
FBRX
Latest News
—
Caricamento notizie per FBRX…
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading